Dr. Elizabeth M. Licalzi, MD

Dr. Licalzi practices at Lifestance Health in Roswell, Georgia.

Dr. Licalzi's NPI, 1629210471, was assigned on March 25, 2009. Dr. Licalzi graduated from SUNY Upstate Medical University in 2009. Dr. Licalzi holds Georgia license 72059.

Dr. Licalzi's primary practice is Lifestance Health, at 11111 Houze Rd Suite 225 Suite 225, Roswell, GA 30076-5618. The practice phone is (770) 603-0123.

Dr. Licalzi's primary practice is Lifestance Health in Roswell, Georgia. The medical group on file is LifeStance Health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Licalzi practices. Vendor and product names are available with a free account.

Psychiatry is Dr. Licalzi's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Licalzi is board certified in psychiatry by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Licalzi's licenses on file in 2 states: Georgia and Tennessee.

Dmand AI lists bipolar disorder, depression, insomnia and tobacco use among the conditions Dr. Licalzi treats.

CMS data shows 179 Medicare services from Dr. Licalzi across 2 procedure codes in 2024, for 17 Medicare patients. Medicare paid $13,577 for them. Every service was in an office.

CMS counts 17 Medicare patients who saw Dr. Licalzi in 2024. 75% of them have anxiety, and 75% have depression. Their average risk score is 1.05, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Licalzi's median patient age at 46, with 76% women.

In 2024, Dr. Licalzi wrote 652 Medicare Part D claims for 38 patients. 92% of them were for generic drugs. CMS names the drug for 526 of them, across 20 drugs with 11 or more claims each, at $27,138 in total drug cost. In 2023, CMS named 587 claims across 27 drugs.

Dr. Licalzi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Licalzi as offering telehealth.

Dmand AI links 2 papers to Dr. Licalzi, published from 2008 to 2010. The most frequent topics are Antimanic Agents, Disruptive, Impulse Control, and Conduct Disorders and Fluorodeoxyglucose F18. Dr. Licalzi has published most often in Neuropsychobiology. Dr. Licalzi's most frequent co-authors are Chelain Rae Goodman, MD, PhD and Stefano Pallanti, MD.

CMS Open Payments shows 299 general payments to Dr. Licalzi from 26 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Otsuka America Pharmaceutical, Inc. paid the most, $652.

Dr. Licalzi graduated from SUNY Upstate Medical University in 2009.

Dr. Licalzi is in network with 10 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.